Expert Review of Neurotherapeutics , December 2012, Vol. 12, No. 12, Pages 1481-1481. more
To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Primary CNS tumors (PCNSTs) encompass a broad and heterogeneous group of tumors, including gliomas, meningiomas, embryonal tumors, primary CNS lymphomas, CNS germ cell tumors and sellar region tumors. In recent decades, research has focused on understanding the clinical and biological significance of molecular abnormalities detected in PCNSTs. The emergence of genomic arrays, including comparative genomic hybridization and SNP arrays, have helped in the discovery of novel critically important genes and novel genomic biomarkers involved in PCNST oncogenesis (e.g., BRAF duplication in pilocytic astrocytoma). Since a summary of data from genomic arrays using gliomas has been described in a previous review, in this article we will focus on the insights provided by genome-wide DNA arrays in the genetics and genomics of nonglial PCNSTs in adults. The high-throughput assessment of gene copy-number abnormalities has improved our knowledge of molecular pathogenesis in nonglial PCNSTs, allowing for the identificati...
| Authors: | Agustí Alentorn; Marc Sanson; Karima Mokhtari; Yannick Marie; Khê Hoang-Xuan; Jean-Yves Delattre; Ahmed Idbaih | |
| Journal: | Expert Review of Molecular Diagnostics | |
| Year: | 2012 | |
| DOI: | 10.1586/erm.12.17 | |
| Publication date: | 02-04-2012 |
Watchlist
This is where you can add this publication to your personal favourites.
Additional Information
Expert Review of Neurotherapeutics , December 2012, Vol. 12, No. 12, Pages 1481-1481. more
Is DaTSCAN really needed for accurate Parkinson’s disease diagnosis?
Expert Review of Neurotherapeutics , December 2012, Vol. 12, No. 12, Pages 1375-1377. more
New concepts in the early and preclinical detection of Parkinson’s disease: therapeutic implications
Parkinson’s disease is a chronic neurodegenerative disorder leading to progressive motor impairment for which there is no cure. Currently, the diagnosis is made by the presence of cardinal motor features and several associated non-motor symptoms. However, at this point, the underlying neuro ... more
Publications